Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Clinical trial NCT05396105 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05396105
Sponsor: Pharvaris Netherlands B.V.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema Hereditary Angioedema Type I Hereditary Angioedema Type II Hereditary Angioedema Types I and II Hereditary Angioedema Attack Hereditary Angioedema With C1 Esterase Inhibitor Deficiency Hereditary Angioedema - Type 1 Hereditary Angioedema - Type 2 Hereditary Angioedema - Type 3 C1 Esterase Inhibitor [C1-INH] Deficiency C1 Esterase Inhibitor Deficiency C1 Esterase Inhibitor, Deficiency of

Start date: 2022-12-28
Primary completion: 2027-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.